Ensign Peak Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
23,136
-3,900
| -14% | -$216K | ﹤0.01% | 1106 |
|
|
2025
Q1 | $1.31M | Hold |
27,036
| – | – | ﹤0.01% | 1106 |
|
|
2024
Q4 | $1.04M | Hold |
27,036
| – | – | ﹤0.01% | 1296 |
|
|
2024
Q3 | $1.22M | Hold |
27,036
| – | – | ﹤0.01% | 1212 |
|
|
2024
Q2 | $937K | Hold |
27,036
| – | – | ﹤0.01% | 1325 |
|
|
2024
Q1 | $782K | Sell |
27,036
-1,364
| -5% | -$39.5K | ﹤0.01% | 1474 |
|
|
2023
Q4 | $651K | Hold |
28,400
| – | – | ﹤0.01% | 1595 |
|
|
2023
Q3 | $474K | Buy |
28,400
+12,100
| +74% | +$202K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $450K | Buy |
+16,300
| New | +$450K | ﹤0.01% | 1654 |
|
|
2022
Q4 | – | Sell |
-12,270
| Closed | -$103K | – | 2117 |
|
|
2022
Q3 | $103K | Buy |
12,270
+1,590
| +15% | +$13.3K | ﹤0.01% | 2088 |
|
|
2022
Q2 | $84K | Hold |
10,680
| – | – | ﹤0.01% | 1995 |
|
|
2022
Q1 | $253K | Hold |
10,680
| – | – | ﹤0.01% | 1812 |
|
|
2021
Q4 | $365K | Buy |
+10,680
| New | +$365K | ﹤0.01% | 1742 |
|
|
2021
Q3 | – | Sell |
-33,230
| Closed | -$1.49M | – | 1872 |
|
|
2021
Q2 | $1.49M | Hold |
33,230
| – | – | ﹤0.01% | 1275 |
|
|
2021
Q1 | $861K | Hold |
33,230
| – | – | ﹤0.01% | 1470 |
|
|
2020
Q4 | $670K | Sell |
33,230
-4,222
| -11% | -$85.1K | ﹤0.01% | 1534 |
|
|
2020
Q3 | $732K | Buy |
+37,452
| New | +$732K | ﹤0.01% | 1426 |
|